ArticleCancer medicine2023

Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non-small cell lung cancer.

Yue Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.